Dr. Lal Pathlabs Ltd.
Snapshot View

View in App

Prices View details >>

1797.00 -13.20 ▼-0.7%

29 March 2023, 04:01:00 PM
Volume: 3,287

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.lalpathlabs.com
Market Cap 15,004.97 Cr.
Enterprise Value(EV) 14,716.07 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 29.21 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 61.52 Trailing Twelve Months Ending 2022-12
Industry PE 46.43 Trailing Twelve Months Ending 2022-12
Book Value / Share 192.32 Trailing Twelve Months Ending 2022-12
Price to Book Value 9.34 Calculated using Price: 1,797.00
Dividend Yield 0.67 Period Ending 2022-03
No. of Shares Subscribed 8.34 Cr. 83,367,877 Shares
FaceValue 10
Company Profile
The company is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.73%
1 Week
-1.78%
1 Month
-9.61%
3 Month
-21.35%
6 Month
-30.68%
1 Year
-31.20%
2 Year
-30.14%
5 Year
+105.43%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 43.95 37.14 32.45 28.45 25.32 23.76 23.74 26.89 26.39
Return on Capital Employed (%) 60.49 48.87 47.43 43.07 37.90 34.78 32.94 36.03 32.60
Return on Assets (%) 27.30 24.67 25.06 24.13 21.81 20.38 18.81 19.87 17.74

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 231 341 507 596 788 946 1,033 1,245 1,508 1,550
Non Curr. Liab. 1 -5 12 -6 -9 -20 70 83 273 226
Curr. Liab. 97 112 91 85 116 138 227 274 500 450
Minority Int. 2 2 3 2 4 5 21 31 35 33
Equity & Liab. 332 450 613 676 899 1,069 1,351 1,633 2,316 2,259
Non Curr. Assets 162 168 189 210 276 255 459 488 1,441 1,424
Curr. Assets 170 282 424 467 623 814 893 1,145 875 835
Misc. Exp. not W/O
Total Assets 332 450 613 676 899 1,069 1,351 1,633 2,316 2,259

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 558 660 791 912 1,057 1,203 1,330 1,581 2,087 2,011
Other Income 8 13 22 28 31 46 55 51 53 40
Total Income 566 673 813 940 1,088 1,249 1,385 1,633 2,140 2,051
Total Expenditure -419 -504 -584 -675 -793 -910 -987 -1,145 -1,527 -1,516
PBIDT 147 168 229 265 295 340 399 488 613 535
Interest 0 0 -1 -1 -1 -1 -15 -16 -30 -40
Depreciation -27 -28 -28 -28 -33 -38 -73 -77 -108 -150
Taxation -39 -43 -67 -81 -90 -100 -83 -98 -125 -98
Exceptional Items
PAT 80 96 133 156 172 200 228 296 350 246
Minority Interest -1 -1 -1 -1 -1 -1 -2 -5 -5 -3
Share Associate
Other Related Items
Consolidated Net Profit 80 96 132 155 171 199 226 292 345 244
Adjusted EPS 14 17 16 19 20 24 27 35 41 29

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 88 98 122 159 171 197 219 284 398 447
Cash Fr. Inv. -65 -90 -113 -163 -137 -172 -100 -26 -212 -449
Cash Fr. Finan. -15 -10 -1 0 -32 13 -55 -190 -139 136
Net Change 8 -2 8 -5 2 37 64 67 48 134
Cash & Cash Eqvt 17 16 23 19 29 66 129 197 244 378

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 55.23 55.23 55.23 55.23 55.23 55.23 55.05 55.05 55.05
Public 44.77 44.77 44.77 44.77 44.77 44.77 44.95 44.96 44.95
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 29 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s).
Mon, 27 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s).
Thu, 23 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s).

Technical Scans View Details >>

Wed, 29 Mar 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.37 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.66 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.90 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 7.53 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.77 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Dr. Lal Pathlabs Ltd.

What is Dr. Lal Pathlabs share price?
Can I buy Dr. Lal Pathlabs shares now?
What is the Dividend Yield of Dr. Lal Pathlabs?
What is the Market Cap of Dr. Lal Pathlabs?
What are the key metrics to analyse Dr. Lal Pathlabs?
What is the 52 Week High and Low of Dr. Lal Pathlabs?
What is the trend of Dr. Lal Pathlabs share price?